Evolus, Inc. (EOLS): Depreciation & Amortization
$7.51M
Year ended 2025-12-31
$8.89M
Trailing 12 months to 2026-06-30
+26.3%
3-year compound annual growth
+1.3%
5-year compound annual growth
| Period ended | Depreciation & Amortization | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $7.51M | +41.7% | 2026-03-03, From 2025-01-01 |
| 2024-12-31 | $5.30M | +3.2% | 2026-03-03, From 2024-01-01 |
| 2023-12-31 | $5.13M | +37.9% | 2026-03-03, From 2023-01-01 |
| 2022-12-31 | $3.72M | -33.8% | 2025-03-04, From 2022-01-01 |
| 2021-12-31 | $5.62M | -20.0% | 2023-03-08, From 2021-01-01 |
| 2020-12-31 | $7.03M | +70.1% | 2022-03-03, From 2020-01-01 |
| 2019-12-31 | $4.13M | n/m | 2021-03-25, From 2019-01-01 |
| 2018-12-31 | $9.0K | -95.9% | 2020-02-25, From 2018-01-01 |
| 2017-12-31 | $218.0K | n/a | 2019-03-20, From 2017-01-01 |
Depreciation & Amortization at similar companies
| Company | Year ended | Depreciation & Amortization | Change YoY |
|---|---|---|---|
| Evolus, Inc. (EOLS) | 2025-12-31 | $7.51M | +41.7% |
| Ironwood Pharmaceuticals Inc (IRWD) | 2025-12-31 | $1.10M | -8.3% |
| Xeris Biopharma Holdings, Inc. (XERS) | 2025-12-31 | $1.31M | +7.0% |
| Harrow, Inc. (HROW) | 2025-12-31 | $1.92M | +3.5% |
| Vireo Growth Inc. (VREOF) | 2025-12-31 | $16.11M | +535.0% |
| Ligand Pharmaceuticals Inc (LGND) | 2025-12-31 | $33.77M | -4.2% |
| Arvinas, Inc. (ARVN) | 2025-12-31 | $3.00M | -34.8% |
| Schrodinger, Inc. (SDGR) | 2025-12-31 | $6.02M | -2.2% |
| MannKind Corp (MNKD) | 2025-12-31 | $12.28M | +66.7% |
Compare EOLS, IRWD, XERS, HROW side by side · Screen every company in Pharmaceutical Preparations ↗